Related Experiment Video

Updated: Jan 30, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K

Development of Preventive Vaccines for Hepatitis C Virus E1/E2 Protein

Faezeh Ghasemi1,2, Majid Ghayour-Mobarhan3, Hamed Gouklani4

  • 1Dept. of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Iranian Journal of Pathology
|January 31, 2019
PubMed

Insights

Hepatitis C virus (HCV) infection chronically affects 3% of the global population, leading to liver failure. Understanding immune responses and antibody interactions is crucial for developing effective HCV vaccines.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) causes significant global morbidity and mortality, being a primary cause of liver failure.
  • Chronic HCV infection affects approximately 3% of the world's population, necessitating effective prevention strategies.

Purpose of the Study:

  • To summarize current vaccine development strategies for Hepatitis C virus (HCV).
  • To highlight the importance of understanding humoral immune responses, antibody interactions, and virus-receptor binding for vaccine design.

Main Methods:

  • Review of existing literature on HCV immunology and vaccine research.
  • Analysis of the roles of structural and non-structural HCV proteins in immune responses.

Main Results:

  • Humoral immune responses primarily target structural HCV proteins.
  • Cellular immune responses are mainly directed against non-structural HCV proteins.
  • Diverse vaccine candidates utilize various combinations of HCV antigens.

Conclusions:

  • A comprehensive understanding of host immune responses against HCV is essential for successful vaccine development.
  • Targeting both structural and non-structural proteins may be necessary for a broadly protective HCV vaccine.

Keywords:
AntibodiesHepatitis CImmunizationPrevention and controlViruses

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K
Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.7K
E2 Reaction: Stereochemistry and Regiochemistry02:43

E2 Reaction: Stereochemistry and Regiochemistry

Elimination reactions of alkyl halides can yield one or more alkenes depending on the specific regiochemical and stereochemical considerations. While the regiochemistry of the reaction governs the location of the double bond in the product, the stereochemical requirements often influence the geometry.
When a substrate with two different β hydrogens undergoes an E2 elimination, the presence of a strong base can yield two regioisomeric alkenes. The more-substituted alkene is the major...
13.6K
E2 Reaction: Kinetics and Mechanism02:45

E2 Reaction: Kinetics and Mechanism

SN2 substitutions and E2 eliminations of alkyl halides proceed via a concerted pathway. While the nucleophile attacks the alpha carbon in SN2 reactions, it functions as a strong base and abstracts a beta hydrogen in the E2 mechanism. The rate-limiting transition state in E2 elimination reactions is characterized by partially broken carbon–hydrogen and carbon–halogen bonds and a partially formed pi bond between the alpha and beta carbons. The beta hydrogen and halide are eliminated...
12.4K
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
547
What are Viruses?00:50

What are Viruses?

Overview
128.1K
E1 Reaction: Kinetics and Mechanism02:46

E1 Reaction: Kinetics and Mechanism

Here, in contrast to the E2 reaction mechanism, we delve into the aspects of the E1 reaction mechanism, which has two steps: rate-limiting loss of the leaving group and abstraction of the beta hydrogen by a weak base. Typically, the experimental proof for the E1 mechanism is via kinetic studies or isotope studies. While the former demonstrates the first-order kinetics—the dependence of the reaction solely on substrate concentration—the latter proves the abstraction of hydrogen only...
17.7K